Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

A Preview Of Copa Holdings’s Earnings

Copa Holdings (NYSE:CPA) is set to give its latest quarterly earnings report on Wednesday, 2022-11-16. Here's what investors need to know before the announcement. Analysts estimate that Copa Holdings will report an earnings per share (EPS) of $2.67.

Copa Holdings (NYSE:CPA) is set to give its latest quarterly earnings report on Wednesday, 2022-11-16. Here’s what investors need to know before the announcement.

Analysts estimate that Copa Holdings will report an earnings per share (EPS) of $2.67.

Copa Holdings bulls will hope to hear the company to announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

Last quarter the company missed EPS by $1.18, which was followed by a 5.48% increase in the share price the next day.

Here’s a look at Copa Holdings’s past performance and the resulting price change:

Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate 1.50 0.29 0.90 -0.11
EPS Actual 0.32 0.70 1.98 0.70
Price Change % 5.48% 2.9% 2.82% 8.93%

eps graph

Stock Performance

Shares of Copa Holdings were trading at $75.1 as of November 11. Over the last 52-week period, shares are up 4.63%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all earnings releases for Copa Holdings visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Cantor Fitzgerald Lowers Price On Trulieve Cannabis Corp Ahead Of Q2 Report, Still Among Top US Picks

On Thursday, Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) introduced a comprehensive brand portfolio, including four distinct brands - Muse, Sweet Talk and Momenta brands and the expansion of the Cultivar Collection - to serve the consumer in both adult-use and medical ma

CSE:CURA